Golden
SVB Leerink

SVB Leerink

SVB Leerink is a Boston headquartered investment bank specializing in healthcare and life sciences.

SVB Leerink is a Boston, Massachusetts based investment bank. They specialize in healthcare and life sciences with the experience and knowledge to help its clients to define and achieve their strategic, capital market and ivnestment objectives. SVB Leerink partners with companies that develop and commercialize innovative products and services in healthcare.



Investment

SVB Leerink has invested in and helped raise money on capital markets for 89Bio, affimed, CentoGene, Evolus, Innate Pharma, Principia Biopharma, Biontech, ProventionBio, Translate, Satsuma Pharmaceuticals and Fate Therapeutics.

Timeline

People

Name
Role
LinkedIn

Dan Dubin, M.D.

Vice Chairman



Jeffrey A. Leerink

Chief Executive Officer



Jim Boylan

President Head of Investment Banking



John L. Sullivan, CFA

Senior Managing Director



Joseph Gentile

Chief Administrative Officer



Maura Polak

Managing Director, Human Resources



Robert Leerink

Senior Managing Director, Head of Institutional Equities



Steven Heineman

Senior Managing Director, General Counsel



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References